Skip to content
10-K

Annual Report

P3 Health Partners Inc. PIII PIIIW

0001832511-26-000011

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2024 · Dec 31, 2025 3.27M sh
Shares Diluted restated FY 2024 · Dec 31, 2024 2.94M sh
Operating Cash Flow FY 2024 · Dec 31, 2025 −$91.24M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$110.13M
Long Term Debt FY 2024 · Dec 31, 2025 $228.37M
Long Term Debt restated FY 2024 · Dec 31, 2024 $108.91M
Cash And Equivalents FY 2024 · Dec 31, 2025 $25.01M
Cash And Equivalents FY 2024 · Dec 31, 2024 $38.82M
Stockholders Equity FY 2024 · Dec 31, 2025 −$155.23M
Stockholders Equity FY 2024 · Dec 31, 2024 $75.94M
Stockholders Equity FY 2024 · Dec 31, 2023 $142.13M
Current Liabilities FY 2024 · Dec 31, 2025 $545.26M
Current Liabilities FY 2024 · Dec 31, 2024 $496.42M
Total Liabilities FY 2024 · Dec 31, 2025 $796.88M
Total Liabilities FY 2024 · Dec 31, 2024 $633.89M
Current Assets FY 2024 · Dec 31, 2025 $133.08M
Current Assets FY 2024 · Dec 31, 2024 $184.14M
Total Assets FY 2024 · Dec 31, 2025 $656.64M
Total Assets FY 2024 · Dec 31, 2024 $783.42M
Eps Diluted FY 2024 · Dec 31, 2025 −$45.26
Eps Diluted restated FY 2024 · Dec 31, 2024 −$54.06
Eps Basic FY 2024 · Dec 31, 2025 −$45.26
Eps Basic restated FY 2024 · Dec 31, 2024 −$46.78
Sga Expense FY 2024 · Dec 31, 2025 $106.31M
Sga Expense FY 2024 · Dec 31, 2024 $112.6M
Net Income FY 2024 · Dec 31, 2025 −$147.95M
Net Income FY 2024 · Dec 31, 2024 −$135.85M
Operating Income FY 2024 · Dec 31, 2025 −$270.3M
Operating Income FY 2024 · Dec 31, 2024 −$320.66M
Revenue FY 2024 · Dec 31, 2025 $1.46B
Revenue FY 2024 · Dec 31, 2024 $1.5B